Determination of the fibrinogenolytic activity of Montivipera raddei (Raddeʼs mountain viper) venom
DOI:
https://doi.org/10.2298/ABS220806029AKeywords:
Fibrinogen, Proteinase, SDS-PAGE, Snake Venom, ZymographyAbstract
Paper description:
- Snake venom fibrinogenolytic enzymes have diagnostic and therapeutic value and are important for snakebite pathology. There is no study in the literature investigating the fibrinogenolytic activity of Montivipera raddei venom.
- SDS-PAGE and zymography were used to assess fibrinogen degradation. HPLC was used to obtain supportive data.
- The presence of fibrinogenolytic serine and metalloproteinases in M. raddei venom is reported in in vitro experiments.
- The presented findings will guide future studies aiming to identify new fibrinogenolytic enzymes and evaluate their biotechnological potential. The results will be useful for the assessment of snakebite pathology.
Abstract: Snake venom fibrinogenolytic enzymes have diagnostic and therapeutic value and are important for snakebite pathology. In the present study, the fibrinogenolytic activity of Montivipera raddei venom was investigated. Crude venom was incubated with human fibrinogen for different times at 37°C. An inhibition study was carried out using different protease inhibitors. The fibrinogenolytic activity was assessed by SDS-PAGE and fibrinogen zymography. An HPLC-based method was used to obtain confirmatory data. Montivipera raddei venom predominantly cleaved the Aα chain of fibrinogen in a time-dependent manner. A very slight decrease in band intensity of the Bβ chain was observable after a longer incubation time. Cleavage of fibrinogen was confirmed by HPLC. Zymography revealed that the venom contained 50 and 75 kDa fibrinogenolytic enzymes. Ethylenediaminetetraacetic acid (EDTA) and 1,10-phenanthroline inhibited the overall fibrinogenolytic activity, while phenylmethylsulfonyl fluoride (PMSF) and aprotinin only inhibited the degradation of the Bβ chain. These results indicated that metalloproteinases were major fibrinogenolytic enzymes in the venom. An inhibitor study suggested the presence of serine proteinases that broke down the Bβ chain. With this study, the fibrinogenolytic activity of M. raddei venom was shown for the first time. The results will be useful for further isolation and characterization studies.
Downloads
References
Chippaux JP. Snake venoms and envenomations. 1st ed. Florida: Krieger Publishing Company; 2006. 287 p.
Phillips DJ, Swenson SD, Markland FS. Thrombin-like snake venom serine proteinases. In: Mackessy SP, editor. Handbook of Venoms and Toxins of Reptiles. 1st ed. Boca Raton: CRC Press; 2010. p. 139-54. https://doi.org/10.1201/9781420008661.ch6
Sajevic T, Leonardi A, Križaj I. Haemostatically active proteins in snake venoms. Toxicon. 2011;57(5):627-45. https://doi.org/10.1016/j.toxicon.2011.01.006
İğci N, Özel Demiralp FD, Yıldız MZ. Cytotoxic activities of the crude venoms of Macrovipera lebetina lebetina from Cyprus and M. l. obtusa from Turkey (Serpentes: Viperidae) on human umbilical vein endothelial cells. Commagene J Biol. 2019;3:110-3. https://doi.org/10.31594/commagene.655929
Nalbantsoy A, Hempel B-F, Petras D, Heiss P, Göçmen B, Iğci N, Yildiz MZ, Süssmuth RD. Combined venom profiling and cytotoxicity screening of the Radde’s mountain viper (Montivipera raddei) and Mount Bulgar Viper (Montivipera bulgardaghica) with potent cytotoxicity against human A549 lung carcinoma cells. Toxicon. 2017;135:71-83. https://doi.org/10.1016/j.toxicon.2017.06.008
İgci N, Özel Demiralp D. A preliminary investigation into the venom proteome of Macrovipera lebetina obtusa (Dwigubsky, 1832) from Southeastern Anatolia by MALDI-TOF mass spectrometry and comparison of venom protein profiles with Macrovipera lebetina lebetina (Linnaeus, 1758) from Cyprus. Arch Toxicol. 2012;86(3):441-51. https://doi.org/10.1007/s00204-011-0763-5
Weisel JW. Fibrinogen and Fibrin. Adv Protein Chem. 2005;70(04):247-99. https://doi.org/10.1016/S0065-3233(05)70008-5
Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem. 2017;82:405-56. https://doi.org/10.1007/978-3-319-49674-0
Kini RM, Koh CY. Metalloproteases affecting blood coagulation, fibrinolysis and platelet aggregation from snake venoms: definition and nomenclature of interaction sites. Toxins. 2016;8(10):284. https://doi.org/10.3390/toxins8100284
Mackessy SP. Thrombin-like enzymes in snake venoms. In: Kini RM, Clemetson KJ, Markland FS, McLane MA, Morita T, editors. Toxins and Hemostasis. 1st ed. Dordrecht: Springer Netherlands; 2010. p. 519-57. https://doi.org/10.1007/978-90-481-9295-3_30
Sanchez EF, Flores-Ortiz RJ, Alvarenga VG, Eble JA. Direct fibrinolytic snake venom metalloproteinases affecting hemostasis: Structural, biochemical features and therapeutic potential. Toxins. 2017;9(12):392. https://doi.org/10.3390/toxins9120392
Swenson S, Markland FS. Snake venom fibrin(ogen)olytic enzymes. Toxicon. 2005;45(8):1021-39. https://doi.org/10.1016/j.toxicon.2005.02.027
Mebert K, Göçmen B, İğci N, Anıl Oğuz M, Karış M, Ursenbacher S. New records and search for contact zones among parapatric vipers in the genus Vipera (barani, kaznakovi, darevskii, eriwanensis), Montivipera (wagneri, raddei), and Macrovipera (lebetina) in northeastern Anatolia. Herpetol Bull. 2015;133:13-22.
Sanz L, Ayvazyan N, Calvete JJ. Snake venomics of the Armenian mountain vipers Macrovipera lebetina obtusa and Vipera raddei. J Proteomics. 2008;71(2):198-209. https://doi.org/10.1016/j.jprot.2008.05.003
Aznaurian AV, Amiryan SV. Histopathological changes induced by the venom of the snake Vipera raddei (Armenian adder). Toxicon. 2006;47(2):141-3. https://doi.org/10.1016/j.toxicon.2004.11.012
Ayvazyan NM, Zaqaryan NA, Ghazaryan NA. Molecular events associated with Macrovipera lebetina obtusa and Montivipera raddei venom intoxication and condition of biomembranes. Biochim Biophys Acta Biomembr. 2012;1818(5):1359-1364. https://doi.org/10.1016/j.bbamem.2012.02.001
Chavushyan VA, Gevorkyan AZh, Avakyan ZE, Avetisyan ZA, Pogosyan MV, Sarkisyan DzhS. The protective effect of Vipera raddei venom on peripheral nerve damage. Neurosci Behav Physiol. 2006;36:39-51. https://doi.org/10.1007/s11055-005-0161-7
Amiryan S. Antitumor activity of disintegrin-like components from the venom of Montivipera raddei. J Cancer Ther. 2011;2(5):752-9. https://doi.org/10.4236/jct.2011.25101
Chippaux JP, Williams V, White J. Snake venom variability: Methods of study, results and interpretation. Toxicon. 1991;29(11):1279-303. https://doi.org/10.1016/0041-0101(91)90116-9
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1-2):248-54. https://doi.org/10.1016/0003-2697(76)90527-3
Edgar W, Prentice CRM. The proteolytic action of ancrod on human fibrinogen and its polypeptide chains. Thromb Res. 1973;2(1):85-95. https://doi.org/10.1016/0049-3848(73)90082-0
Lazar Jr. I, Lazar Sr. I. GelAnalyzer 19.1 [Internet]. Lazar Jr. & Lazar Sr.; 2010 [updated 2019, cited 2022 Aug 06]. Available from: http://www.gelanalyzer.com/.
Siigur J, Aaspõllu A, Siigur E. Biochemistry and pharmacology of proteins and peptides purified from the venoms of the snakes Macrovipera lebetina subspecies. Toxicon. 2019;158:16-32. https://doi.org/10.1016/j.toxicon.2018.11.294
Carone SEI, Menaldo DL, Sartim MA, Bernardes CP, Caetano RC, da Silva RR, Cabral H, Barraviera B, Ferreira Junior RS, Sampaio SV. BjSP, a novel serine protease from Bothrops jararaca snake venom that degrades fibrinogen without forming fibrin clots. Toxicol Appl Pharmacol. 2018;357:50-61. https://doi.org/10.1016/j.taap.2018.08.018
De Oliveira DGL, Murakami MT, Cintra ACO, Franco JJ, Sampaio SV, Arni RK. Functional and structural analysis of two fibrinogen-activating enzymes isolated from the venoms of Crotalus durissus terrificus and Crotalus durissus collilineatus. Acta Biochim Biophys Sin. 2009;41(1):21-9. https://doi.org/10.1093/abbs/gmn003
Serrano SMT. The long road of research on snake venom serine proteinases. Toxicon. 2013;62:19-26. https://doi.org/10.1016/j.toxicon.2012.09.003
Ullah A, Masood R, Ali I, Ullah K, Ali H, Akbar H, Betzel C. Thrombin-like enzymes from snake venom: Structural characterization and mechanism of action. Int J Biol Macromol. 2018;114:788-811. https://doi.org/10.1016/j.ijbiomac.2018.03.164
Marsh N, Williams V. Practical applications of snake venom toxins in haemostasis. Toxicon. 2005;45(8):1171-81. https://doi.org/10.1016/j.toxicon.2005.02.016
Arıkan H, Alpagut Keskin N, Çiçek K. Fibrinogenolytic activity of venom proteins of Montivipera xanthina (Gray, 1849) (Ophidia: Viperidae). Basic Appl Herpetol. 2017;31:91-100. https://doi.org/10.11160/bah.58
Preciado LM, Pereañez JA. Low molecular mass natural and synthetic inhibitors of snake venom metalloproteinases. Toxin Rev. 2018;37(1):19-26. https://doi.org/10.1080/15569543.2017.1309550
Zaqueo KD, Kayano AM, Domingos TFS, Moura LA, Fuly AL, da Silva SL, Acosta G, Oliveira E, Albericio F, Zanchi FB, Zuliani JP, Calderon LA, Stábeli RG, Soares AM. BbrzSP-32, the first serine protease isolated from Bothrops brazili venom: Purification and characterization. Comp Biochem Physiol Part A Mol Integr Physiol. 2016;195:15-25. https://doi.org/10.1016/j.cbpa.2016.01.021
Siigur J, Aaspollu A, Tonismägi K, Trummal K, Samel M, Vija H, Subbi J, Siigur E. Proteases from Vipera lebetina venom affecting coagulation and fibrinolysis. Haemostasis. 2001;31:123-32. https://doi.org/10.1159/000048055
Damm M, Hempel BF, Süssmuth RD. Old World Vipers—A review about snake venom proteomics of Viperinae and their variations. Toxins. 2021;13(6):427. https://doi.org/10.3390/toxins13060427
Alvarez-Flores MP, Faria F, de Andrade SA, Chudzinski-Tavassi AM. Snake venom components affecting the coagulation system. In: Gopalakrishnakone P, Inagaki H, Vogel C-W, Mukherjee AK, Rahmy TR, editors. Snake Venoms. 1st ed. Dordrecht: Springer Netherlands; 2017. p. 417-37. https://doi.org/10.1007/978-94-007-6410-1_31
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.